Literature DB >> 28796656

Hypothyroidism Potentially Linked to Cutaneous Squamous Cell Carcinoma: Retrospective Study at a Single Tertiary Academic Medical Center.

Omeed Ahadiat1,2, Shauna Higgins1, Cameron Trodello1, Guy Talmor1, Niels Kokot3, Ashley Wysong1.   

Abstract

BACKGROUND: There are multiple known risk factors for the development of cutaneous squamous cell carcinoma (SCC).
OBJECTIVE: To determine whether patients with cutaneous SCC have a higher prevalence of hypothyroidism than the general US population.
MATERIALS AND METHODS: A retrospective review was performed for patients seen at the University of Southern California with cutaneous SCC. Chart review was performed for the presence of hypothyroidism and thyroid replacement therapy before the diagnosis of SCC for each patient. Multiple prevalence studies were gathered from the literature for comparison, reporting the prevalence of overt and subclinical hypothyroidism in the general US population and/or elderly US population.
RESULTS: Of the 265 patients diagnosed with SCC of the skin, 61 (23%) of patients were found to have a preceding diagnosis of hypothyroidism. The prevalence of hypothyroidism among the population of SCC patients was significantly greater than the prevalence of hypothyroidism (overt and subclinical) in any general and/or elderly US population reported.
CONCLUSION: Patients with SCC of skin are more likely to have a history of hypothyroidism than the general population. The authors conclude that hypothyroidism may be linked to the development of cutaneous SCC.

Entities:  

Mesh:

Year:  2018        PMID: 28796656     DOI: 10.1097/DSS.0000000000001241

Source DB:  PubMed          Journal:  Dermatol Surg        ISSN: 1076-0512            Impact factor:   3.398


  1 in total

1.  Association of Hypothyroidism With Nonmelanoma Skin Cancer in the Multiethnic Cohort Population-Based Study.

Authors:  Omeed Ahadiat; Veronica W Setiawan; Shauna Higgins; Jacqueline Porcel; Christopher Haiman; Loïc Le Marchand; Lynne Wilkens; Ashley Wysong
Journal:  Dermatol Surg       Date:  2019-01       Impact factor: 3.398

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.